Allarity Therapeutics, Inc. (ALLR)

NASDAQ: ALLR · IEX Real-Time Price · USD

0.168

-0.018 (-9.92%)

At close: Jul 19, 2024, 4:00 PM

0.165

-0.003 (-2.02%)

Pre-market: Jul 22, 2024, 7:44 AM EDT

Allarity Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	0	0	0	0	0	0.12
Gross Profit	0	0	0	0	0	0.12
Selling, General & Admin	9.86	10.03	9.96	12.36	4.1	3.87
Research & Development	7.85	7.1	6.93	14.2	4.22	6.37
Other Operating Expenses	0	0	17.57	0	0	7.49
Operating Expenses	17.7	17.13	34.46	26.56	8.32	17.73
Operating Income	-17.7	-17.13	-34.46	-26.56	-8.32	-17.61
Interest Expense / Income	0.51	0.5	0.22	1.85	0.32	3.31
Other Expense / Income	-5.9	-5.81	-17.11	-1.89	-2.24	-2.03
Pretax Income	-12.31	-11.82	-17.58	-26.52	-6.4	-18.89
Income Tax	0.08	0.08	-1.52	0.13	0.2	-4.58
Net Income	-12.39	-11.9	-16.06	-26.65	-6.6	-14.31
Preferred Dividends	8.55	8.52	4.99	0	0	0
Net Income Common	-20.94	-20.42	-21.05	-26.65	-6.6	-14.31
Shares Outstanding (Basic)	175	0	0	0	0	0
Shares Outstanding (Diluted)	175	0	0	0	0	0
Shares Change	33094.32%	29175.59%	49.78%	94.02%	160.00%	-
EPS (Basic)	-410.14	-205.20	-61868.40	-117320.00	-56840.00	-322000.00
EPS (Diluted)	-410.14	-205.20	-61868.40	-117320.00	-56840.00	-322000.00
Free Cash Flow	-11.03	-12.75	-16.03	-13.88	-7.25	-10.12
Free Cash Flow Per Share	-0.06	-128.04	-47100.66	-61120.97	-62213.23	-223466.03
Gross Margin	-	-	-	-	-	100.00%
Operating Margin	-	-	-	-	-	-14675.83%
Profit Margin	-	-	-	-	-	-11927.50%
Free Cash Flow Margin	-	-	-	-	-	-8434.17%
EBITDA	-11.78	-11.28	-17.3	-24.56	-6	-15.49
EBITDA Margin	-	-	-	-	-	-12910.83%
Depreciation & Amortization	0.03	0.04	0.06	0.11	0.09	0.09
EBIT	-11.81	-11.32	-17.36	-24.67	-6.08	-15.58
EBIT Margin	-	-	-	-	-	-12981.67%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).